US Silicone Breast Implants Market - 2024-2031

Overview

The US silicone breast implants market reached US$ 551.0 million in 2023 and is expected to reach US$ 995.1 million by 2031, growing at a CAGR of 7.7% during the forecast period 2024-2031.

Silicone breast implants are medical devices designed for breast augmentation or reconstruction. They consist of a silicone outer shell filled with a cohesive silicone gel or sometimes saline (a saltwater solution). The primary purpose of these implants is to enhance the size, shape, and aesthetic appearance of a person's breasts, or to restore breast volume after mastectomy due to breast cancer or other medical conditions.

Silicone breast implants are widely preferred for both cosmetic and reconstructive surgeries in the United States. In particular, they are highly sought after for breast augmentation, one of the top cosmetic procedures in the U.S. Additionally, there is an increasing adoption of silicone breast implants in the United States. For instance, according to the Cleveland Clinic, In the United States, approximately 3.5 million people have breast implants. About 60% of breast implants contain silicone gel.

Market Dynamics: Drivers & Restraints

Rising demand for aesthetic procedures

Rising demand for aesthetic procedures is significantly driving the growth of the silicon breast implants market in the US and is expected to drive the market over the forecast period. Silicone breast implants are widely chosen for breast augmentation, which is one of the most common cosmetic surgeries in the U.S. According to the Cleveland Clinic, every year, around 300,000 people have breast augmentation surgery in the United States, with a significant portion opting for silicone implants due to their natural feel and appearance.

The media, including social media platforms, has helped normalize and glamorize cosmetic surgery. Celebrities who openly share their cosmetic enhancement experiences further promote these procedures, influencing a growing number of individuals to consider breast implants for aesthetic purposes, this further driving the demand for silicon breast implants in the United States. Over the past decade, there has been a cultural shift toward greater acceptance of aesthetic procedures, including breast augmentation. The U.S. has seen a surge in body image consciousness, with many individuals striving for enhanced aesthetics, which is pushing demand for silicone implants.

For instance, in November 2023, Allergan Aesthetics, an AbbVie company, embraced the immensely personal choice that patients experience when choosing breast surgery. The new Natrelle campaign, "For Every BODY," highlights patients and their diverse stories, leveraging new imagery and visual assets. The campaign showcases how the Natrelle breast implant portfolio can provide a customized look for every curve, for every shape and for every BODY.

Technological improvements in silicone implant materials such as cohesive gel implants or "gummy bear" implants have made the procedure more appealing due to reduced risks of rupture and a more natural appearance. These innovations cater to patient desires for safety and aesthetic enhancement, bolstering demand for silicone implants. The use of 3D imaging technology to plan surgeries allows for more precise and customized results, which has further fueled the demand for breast implants as patients increasingly seek procedures tailored to their specific preferences

High costs of the implants

The cost of silicon breast implants is expected to hamper the growth of the market in the United States. The cost of breast augmentation, including silicone implants is costly depending on factors like the surgeon's fees, location and the complexity of the surgery. These costs are often not covered by insurance for cosmetic procedures, making them inaccessible to many potential patients.

For instance, At NuBody Concepts, a cosmetic surgery center in Nashville and Memphis, Tennessee, the average cost of a breast augmentation is $6,200 for saline implants and $7,100 for silicone implants. Beyond the initial cost of the implants, there are additional expenses for anesthesia, post-surgery medications, follow-up appointments and potential future procedures (e.g., implant replacement after 10-15 years). These ongoing costs deter patients, especially those without disposable income.

With the rising popularity of less invasive body contouring procedures, such as fat transfer breast augmentation and injectable fillers, many consumers are opting for cheaper, less invasive options. These alternatives are perceived as lower-risk and more affordable, further diverting attention from silicone implants

Segment Analysis

The US Silicone Breast Implants market is segmented based on product type, application, end-user and region.

Application:

The breast augmentation segment is expected to dominate the US silicone breast implants market share

The breast augmentation segment holds a major portion of the silicone breast implants market share in the United States and is expected to continue to hold a significant portion of the market share over the forecast period. Breast augmentation consistently ranks as one of the most popular cosmetic surgeries in the U.S. According to the Cleveland Clinic, annually, there are over 300,000 breast augmentation procedures performed, making it one of the leading aesthetic surgeries. A large portion of these procedures uses silicone implants due to their natural look and feel compared to saline alternatives.

Silicone implants are often the preferred choice for breast augmentation due to their realistic appearance and feel. Unlike saline implants, silicone implants mimic the natural softness and texture of breast tissue, which is why they dominate the breast augmentation segment. Social media platforms, especially Instagram and YouTube, have become spaces where people share their cosmetic surgery experiences, thus increasing awareness and demand for procedures like silicone breast implants in the United States.

Competitive Landscape

The major US players in the silicone breast implants market include Allergan Inc., Mentor Worldwide LLC, Sientra, Inc., Ideal Implant Incorporated and among others.

Why Purchase the Report?

• Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
• Market Positioning: Analysis of product performance and growth potential for optimized strategies.
• Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
• Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
• Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
• Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
• Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
• Market Expansion: Strategies for entering new markets and forming partnerships.
• Regional Opportunities: Identification of high-growth regions and investment prospects.
• Supply Chain Optimization: Assessment of risks and distribution strategies.
• Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
• Post-Market Surveillance: Enhanced safety and access through post-market data.
• Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The US silicone breast implants market report delivers a detailed analysis with 21 key tables, more than 22 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.